Attorneys for parents and Abbott Laboratories faced off during opening arguments Monday in the first Chicago trial over ...

The latest chapter in an ongoing legal battle between Abbott Laboratories and parents of babies born prematurely is slated to ...

Abbott Laboratories’ modelled fair value has been adjusted only fractionally, from US$133.39 to US$133.33 per share, keeping the core price target effectively stable in absolute terms. That tiny shift ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Abbott Laboratories (NYSE:ABT) ...

Jury selection in Cook County is set to kick off this week in a closely watched courtroom battle over Abbott Laboratories’ ...

Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund holders during the fourth quarter of 2025. On February 20, the company ...

"Boring" may be just what the doctor ordered in this volatile market.

This company has delivered earnings and dividend growth over time. Abbott’s innovation and a new acquisition could spur more growth in the years to come. 10 stocks we like better than Abbott ...

The stock's fall snapped a three-day winning streak.

Abbott Laboratories Inc. defeated a proposed class action alleging it disclosed the protected health data of consumers to ...

Shares of Abbott Laboratories (NYSE: ABT) recently plunged after the company announced its fourth-quarter results. Over the trailing 12 months, the stock is down 16%. Some might choose to stay away ...

Shares of Abbott Laboratories ABT shed 1.33% to $109.56 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to 6,740.02 and ...